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Introduction: Home-nebulizers are a potential source of bacterial infection of the respiratory tract in patients suffering from cystic fibrosis.
Recommendations for disinfecting this equipment are often arbitrary and sometimes contradictory.
Objective: To assess in vitro the effectiveness of 5 methods of disinfecting this equipment.
Methods: 160 mouthpieces and 160 masks of nebulizers were artificially and massively contaminated with 16 strains of germs found in
patients with cystic fibrosis (Staphylococcus aureus, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Burkholderia cenocepacia,
Alcaligenes xylosoxydans). A controlled comparison was carried out of the five methods of disinfection (hypochlorite solution (0.02% active
chlorine), acetic acid 3.5%, Hexanios 0.5%, washing-up detergent 0.5% and a dishwasher), tested with and without drying. Standardised
bacteriological sampling took place 4 h after disinfecting.
Results: Following treatment, the disappearance of the germ was recorded in 84.1% of cases, and effective disinfecting (reduction>5 log
CFU/mL) in another 10.6%. Disinfection failure (5.3%) was found almost only in the case of acetic acid against Staphylococcus aureus.
Conclusion: With the exception of acetic acid, the methods of disinfecting tested in this study appeared to be effective against common
bacterial pathogens in cystic fibrosis.
D 2005 Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.Keywords: Contamination; Cystic fibrosis; Disinfection; In vitro; Nebulizer1. Introduction
Most patients suffering from cystic fibrosis (CF) regu-
larly use nebulizers. The substances most often delivered by
this route are antibiotics, rhDNase, conventional mucolytics,
saline and bronchodilators [1,2].1569-1993/$ - see front matter D 2005 Published by Elsevier B.V. on behalf of E
doi:10.1016/j.jcf.2005.06.001
i Results were presented at 26th European CF Conference, Belfast 2003.
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taires Saint-Luc, Universite´ Catholique de Louvain (UCL), Avenue
Hippocrate 10, B-1200, Brussels, Belgium. Tel.: +32 2 764 19 39; fax:
+32 2 764 89 06.
E-mail address: gregory.reychler@clin.ucl.ac.be (G. Reychler).Bacterial infection plays a major role in the process
leading to respiratory failure in this disease. CF respiratory
pathogens are commonly isolated from used nebulizers so
there is a concern that this equipment may be a source of
bacterial infection of the lower airways [3–6]. Cleaning and
sterilization or disinfection of respiratory therapy equipment
is now considered essential to prevent infections of these
patients [7].
There is a need to address nebulizer cleaning methods as
in practice current recommendations appear to vary and
sometimes to be contradictory [1]. In 2002, for example, the
official site of the French Cystic Fibrosis Association4 (2005) 183 – 187uropean Cystic Fibrosis Society.
Table 1
Numbers of strains used
Strain No
Methicillin-resistant Staphylococcus aureus (MRSA) 2
Methicillin-sensitive Staphylococcus aureus (MSSA) 2
Pseudomonas aeruginosa 8
-non-mucoid (5)
-mucoid (3)
Stenotrophomonas maltophilia 2
Alcaligenes xylosoxydans 1
Burkholderia cenocepacia 1
G. Reychler et al. / Journal of Cystic Fibrosis 4 (2005) 183–187184recommended the use of relatively concentrated solutions of
hypochlorite (0.36% of active chlorine) while its German
counterpart specifically warned against the use of this
substance, considered to be an irritant. Some manufacturers
recommend to use soap for cleaning and boiling water for
disinfection.2. Objectives of the study
The purpose of this study was to assess the in vitro
efficacy of 5 methods of disinfection on mouthpieces and
facemasks of nebulizers. The choice of the methods to be
tested was based on CF specific data from the literature [3,8]
and recommendations of national cystic fibrosis associa-
tions. Boiling water was not considered due to risks of
burns.3. Material and methods
160 polypropylene and PVC masks (1100E, Medic-Aid,
Brussels) and 160 polypropylene mouthpieces (1605,
Medic-Aid, Brussels) were contaminated in a massive and
standardised way by strains from culture broths of patho-
genic germs frequently found in CF (Table 1). Each of the
sixteen strains contaminated 20 nebulizers (10 masks and 10
mouthpieces) of which 10 were disinfected with drying and
8 without. A mask and a mouthpiece per strain were not
disinfected and were used as controls (Fig. 1).Fig. 1. Scheme of the expContamination was carried out with a germ culture broth
(5 mL of BHI broth-incubation for 18 h at 37 -C-addition
of 0.5 mL of bovine albumin at 30% to simulate the
presence of organic debris). An equal quantity (0.1 mL) of
this broth was spread on a particular surface of the
nebulizer part, identical in each case. Dilutions of the
broth were made to determine the concentration of germs
present.
The five methods of disinfection tested were the use of a
dishwasher (temperature: 70 -C) or immersion for 20 min in
a litre of one of the 4 following solutions: Hexanios 0.5%
(ANIOS Laboratories, Lille, France), shop-purchased hypo-
chlorite solution (0.02% of active chlorine), acetic acid at
3.5%, hot water (40 -C)+washing-up detergent (SUN\) at
0.1%.
Apart from the dishwasher (where drying is automati-
cally included in the programme), each technique was
investigated with and without active drying. Following
rinsing in tap water, the parts were either left to dry in the air
or dried with a hairdryer.
A bacteriological assessment sample was taken at the
place of contamination 4 h after this. For the masks, the
surface contaminated was flattened on a count-tac plate. For
the mouthpieces, a cotton swab soaked in a Letheen broth
was used to rub the interior and exterior surfaces, then
cultured on a Columbia blood agar. The result for the
sample was read for the first time after 24 h of incubation at
37 -C. The sample was allowed to remain at ambient
temperature for 6 days, after which the result was re-read,
and compared to the initial load. The number of colonies
present was expressed as a common logarithm.
Disinfection was defined by a reduction in the bacterial
load greater than or equal to 5 log CFU/mL [9].4. Results
The initial concentrations of germs in the culture broths
used for contamination were the following: 7.8 to 8.1 log
CFU/mL for Staphylococcus aureus, 7.3 to 8.1 log CFU/mL
for Pseudomonas aeruginosa, 7.7 log CFU/mL for Achro-
mobacter xylosoxydans , 7.3 to 8.2 log CFU/mL forerimental protocol.
Table 2
Initial bacterial load (log CFU/mL) versus after disinfection bacterial load (log CFU/mL) (corresponding to the smallest reduction of bacterial load) obtained at
the end of incubation (6 days) for the 5 methods
MSSA MRSA Ps. aer S. malt A. xylo B. ceno
1 2 1 2 1 2 1 2 1 2 1 2
Hexanios 0.5% 8.1 1 7.8 0.6 7.1 / 7.3 / 7.7 / 5.2 /
Hypochlorite solution 
    (0.02% active chlorine)
8.1 0.3 7.8 1.2 7.1 / 7.3 / 7.7 / 5.2 /
Hot water and 0.1% detergent 8.1 1.1 7.8 1.7 7.1 / 7.3 / 7.7 / 5.2 /
3.5% acetic acid 8.1 6.1 8.1 6.1 7.1 / 7.3 0.5 7.7 / 5.2 2.6
Dishwasher 8.1 0.7 7.8 0.7 7.1 / 7.3 / 7.7 / 5.2 /
With 
drying
Hexanios 0.5% 8.1 / 7.8 / 7.1 / 7.3 / 7.7 / 5.2 /
Hypochlorite solution 
    (0.02% active chlorine)
8.1 / 7.8 0.3 7.1 / 7.3 / 7.7 / 5.2 /
Hot water and 0.1% detergent 8.1 1.5 7.8 5.8 7.1 / 8 1.2 7.7 / 5.2 /
3.5% acetic acid 8.1 8.1 8.1 6.1 8 2 7.3 / 7.7 / 5.2 /
Without
drying
1 : before disinfection.
2 : at the end of incubation (6 days after disinfection).
/  : total disappearance of the germs.
   : reduction <5 log CFU/mL=failure of disinfection. 
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kholderia cenocepacia. The results obtained after imple-
mentation of the disinfection methods are summarized in
Table 2.
Acetic acid was not effective against Staphylococcus
aureus (7 failures out of 8), but the other methods tested all
resulted in effective disinfecting or even disappearance of this
bacterium.
All the methods tested, whether followed by drying or
not, were effective against Pseudomonas aeruginosa,
Stenotrophomonas maltophilia and Achromobacter xyloso-
xydans. With drying, all the methods brought about the total
disappearance of these bacteria, with the exception of acetic
acid in the case of Stenotrophomonas maltophilia. Without
drying, acetic acid and hot water with detergent did not
completely get rid of, respectively, Pseudomonas aerugi-
nosa and Stenotrophomonas maltophilia.
With drying, acetic acid was ineffective against Bur-
kholderia cenocepacia (reduction of the minimal concen-
tration of only 2.6 log), while all other methods caused this
bacterium to disappear completely.
The methods tested proved to be equally effective with
the mask and the mouthpiece, even though the surfaces and
materials of which they are made differ.5. Discussion
A recent European survey showed that in 95% of 54 CF
centers, treatment with nebulizers is prescribed in at least
half of patients from 9 to 19 years [1].
Nebulizers are considered by the CDC to be semi-critical
elements in the prevention of nosocomial infections [10].The risk of nebulizer equipment contamination has been
documented not only in patients with cystic fibrosis [4–6],
but also in asthmatics [11,12], immunodeficient patients, in
intensive care units [13,14] and in units for serious burn
victims [15].
With regard to cystic fibrosis, this risk is all the greater as
the patients are infected [6]. In reality it probably remains
relatively low, as is shown by the lack of concordance
between the samples taken from the nebulizer equipment
and the sputum [4,5], but it is recurrent, because of the often
daily recourse of such patients to this method of treatment.
There is a consensus that the disinfecting of this
equipment should be preceded by cleaning and followed
by rinsing [16]. Complete cleaning prior to disinfection is
required to remove all organic and inorganic debris and also
helps to maintain the effectiveness of the nebulizers and the
quality of the nebulization [17].
With regard to disinfecting this material at home,
practices remain very disparate [1]. Studies are few and
recommendations various, sometimes even contradictory.
Jakobsson recommended daily steeping for an hour in a
vinegar solution (2%) or for some minutes in boiling water
and showed that observing precise recommendations could
limit the risk of contamination of the nebulizer equipment
[8,18]. The use of hypochlorite solution has been proposed
by others but at very variable frequencies and, above all,
very variable concentrations of active chlorine. Hutchinson
et al. [3] reported weekly disinfection with a solution of
0.0125% of active chlorine, without specifying the steeping
time. Recent recommendations of the French Cystic
Fibrosis Association (AFLM) mention solutions of 0.36%
and then 0.08% of active chlorine with a duration of
immersion from 15 to 30 min; those of the American
G. Reychler et al. / Journal of Cystic Fibrosis 4 (2005) 183–187186Cystic Fibrosis Foundation a solution of 0.13% of active
chlorine with an immersion of 3 min. The German
Association cautions against hypochlorite use and recom-
mends boiling water. Rosenfeld actually trivialises the
various recommendations by reporting that after nebuliza-
tion of a cocktail of Staphylococcus aureus and mucoid
and non-mucoid Pseudomonas aeruginosa, simple rinsing
of the material for a minute in running water, allowing it to
dry in the air, led to the complete disappearance of the
germs in 89% of cases [19].
In the conditions of our study, with the exception of
acetic acid, the methods tested all proved effective against
the principal pathogens encountered in cystic fibrosis.
Acetic acid does not guarantee disinfection for Staph-
ylococcus aureus, nor for Burkholderia cenocepacia and in
fact its use must be considered inadequate [16]. The
effectiveness of the dishwasher has probably to be
relativised because it was studied during a cycle without
any other item, which would appear impractical and
expensive for daily use, and because the maximum temper-
ature reached by some machines (<70 -C) may constitute
another limiting factor. At the low concentration used, the
household bleach (5 ml of bleach (3.61% of active
chlorine)+ 995 ml of water) is odourless and does not stain
clothes. Its low cost makes it particularly attractive.
Several potential limitations of this work may be
discussed.
The localised contamination was achieved on the basis of
a highly concentrated germ broth (108 bacteria/mL) [6], but
only a small quantity of this broth (0.1 mL) was used each
time. In addition, the items were contaminated by only one
strain at a time.
The material used was new. Wear and tear can make the
surfaces more irregular and so more difficult to disinfect.
The study does not show the benefit of drying. But
neither does it call into question an advantage which is now
recognised by all, all the more so as several of the most
pathogens in cystic fibrosis (Pseudomonas aeruginosa and
Burkholderia cenocepacia in particular) are hydrophilic.
Drying is a highly placed priority for disinfection and
cleaning [3]. In fact, the surfaces studied here were very
accessible and dried very well, conceivably even in the air,
within a few hours.
The effectiveness of the methods was only tested 4 h
after being applied. In a quite similar study, Vassal et al. did
not however show any difference between the results of
samples taken at 0, 6 and 24 h [6].
Finally, these results were obtained in laboratory
conditions and it still necessary to validate them by an in
vivo study.6. Conclusion
In the conditions of this in vitro study, with the exception
of acetic acid, the disinfection methods tested provedefficient against the principal pathogens found in cystic
fibrosis. This was particularly the case with a hypochlorite
solution at a very low concentration (0.02% of active
chlorine). In practice, we recommend to clean dismanteled
parts of nebulizer with water and detergent after each
nebulization. Then pieces must be rinsed with tap water,
dried actively and stored in a clean towel. Once a day,
disinfection is recommended after cleaning . The pieces are
putted for 20 min in an hypochlorite solution (5 mL of
hypochlorite diluted in 1 L of water). This solution must be
renewed each day.Acknowledgement
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